Nico Callewaert, Ph.D., serves as the VIB Science Director at the VIB-UGent Center for Medical Biotechnology and is a distinguished Professor in Biochemistry and Biotechnology at Ghent University. His cutting-edge research in glycobiology, microbial biotechnology, and molecular diagnostics has paved the way for innovative biomarker discovery and therapeutic solutions. Notably, his work on non-invasive diagnostic tools, such as the breakthrough GlycoCirrhoTest, has significantly advanced early detection strategies in liver disease and cancer.

At the helm of a dynamic research group, Nico seamlessly integrates robust scientific expertise with strategic innovation to transform molecular technology into real-world healthcare solutions. His leadership fosters impactful interdisciplinary collaborations with academic, biotech, and pharmaceutical partners—positioning the VIB-UGent Center as a premier hub for medical biotechnology and immunotherapy research.

Awarded prestigious grants and recognized globally for his contributions, Nico Callewaert continues to push the boundaries of biopharmaceutical research. His dedication to developing state-of-the-art diagnostics and therapeutic strategies not only accelerates the transition from bench to bedside but also reinforces his status as a visionary leader in the field.